Navigation Links
Therigy CEO Invited to Duke Margolis Center for Health Policy FDA REMS Panel

MAITLAND, Fla., June 1, 2016 /PRNewswire/ -- Therigy CEO and Chief Clinical Officer, Russel Allinson, RPh, will participate in the Duke Margolis Center for Health Policy Workshop: Building a Common REMS Platform taking place June 7, 2016, in Washington, DC.

Photo -

The event is being conducted as part of the FDA's commitment under the Prescription Drug User Fee Act (PDUFA) to make strides toward improving its Risk Evaluation and Mitigation Strategies (REMS) program.  The workshop will be the first step in the FDA's development of a series of "Use Cases" that will model how stakeholders and systems interact to perform important REMS activities.  

Under a cooperative agreement with FDA, the Duke Margolis Center for Health Policy is hosting the day-long conference to:

1) Present the FDA's vision for a common REMS platform and obtain feedback on those aspects of the platform that are ready for further development

2) Identify existing data standards and partnerships that may be leveraged in order to facilitate the development and broader uptake of REMS common data standards

3) Explore innovative new tools and systems that may be developed under the common REMS platform

As a founder and the clinical architect of the leading therapy management software for specialty drug therapies, Allinson was invited to share his insights and provide comment as to how REMS requirements can and should be seamlessly integrated within automated care plans.

"As a part of our development process with TherigySTM, we researched all of the specialty drugs in the market that have REMS requirements and configured those requirements into our software." said Allinson.  "We've carefully thought through what our pharmacy customers need for REMS compliance and reporting.  We've been implementing those solutions in the marketplace through TherigySTM.  I'm honored that our work in this area has been recognized, and I'm looking forward to sharing what we've learned during this important forum."

About Duke-Robert J. Margolis, MD Center for Health Policy

Founded in 2015, Duke-Robert J. Margolis, MD Center for Health Policy connects the intellectual resources at Duke with policymakers and policy analysts in the public and private sector. 

About Therigy

Therigy is the trusted source for innovative, best-in-class software and expert consulting services to the specialty pharmaceutical market. Clients leverage Therigy's solutions, data, and insights to achieve clinical and economic success by aligning strategy, technology, and people.

About TherigySTM

TherigySTM is the leading specialty pharmacy therapy management software used by the industry's most respected specialty pharmacies. TherigySTM helps pharmacies provide superior care to patients with specific clinical support to maximize adherence and improve outcomes. The application allows for accurate and reliable data collection and reporting. TherigySTM is integrated with leading pharmacy dispensing systems and contains pre-configured care plans based on best practice guidelines; helps meet accreditation reporting requirements; and provides a turn-key application that requires little if any additional clinical development by the subscriber. TherigySTM is the only pharmacy care management application where the subscription includes regular releases for new drugs, new indications, and changes to prescribing information. TherigySTM also allows for easy customization of content by subscribers.

This content was issued through the press release distribution service at For more info visit:

To view the original version on PR Newswire, visit:

SOURCE Therigy
Copyright©2016 PR Newswire.
All rights reserved

Related medicine technology :

1. TherigySTM Establishes Market Leadership as the #1 Therapy Management Software for Specialty Pharmacies
2. PuraMed BioScience Invited to Discuss LipiGesic M on Armed Forces Network
3. Schools Nationwide Invited to Join the JDRF Kids Walk to Cure Diabetes
4. Ellen Presby of The Nemeroff Law Firm Invited to Speak at Plaintiff-Only GranuFlo and Dialysis Products Seminar
5. Coherus Biosciences Invited to Present at 2014 J.P. Morgan Annual Healthcare Conference
6. Ensil Canada is Launching a New Medical Device: Publicly Traded Companies Are Invited to Acquire This Technology or Partner with Ensil Canada on the Marketing and Distribution of This New Device
7. Edwards CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation
8. DelMar Pharmaceuticals Invited to Present at The World NSCLC Summit on June 23-24, 2015
9. MEDIA INVITED: Immunomic Therapeutics, Inc., Talks Vital Vaccine Technology Advancement at Biotech Showcase 2016
10. BioElectronics Invited to Present Chronic Pain Patient Observation Study at the British Pain Society Congress
11. New Prescription Fulfillment Service Selects inContact To Rapidly Build Contact Center Operations
Post Your Comments:
(Date:10/12/2017)... 2017 West Pharmaceutical Services, Inc. ... injectable drug administration, today announced that it will release ... Thursday, October 26, 2017, and will follow with a ... at 9:00 a.m. Eastern Time. To participate on the ... conference ID is 94093362. ...
(Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance ... a medical-grade battery-powered display stand specifically designed for endoscopy environments. An ... technology into a clinical solution to support the improvement of patient ... Innovative Design ... Wireless Solution ...
(Date:10/4/2017)... 2017  According to the Centers for Disease Control and Prevention (CDC), ... PhysicianOne Urgent Care is helping communities across Massachusetts , ... by offering no-cost* flu shots through the end of the month. ... insurance regulations. ... get a flu shot is by the end of October, according to ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
Breaking Medicine News(10 mins):